Multiple Ascending Dose Study to Evaluate the Safety, Tolerability of DC371739 Treatment in Hypercholesterolemic

Clinical trial NCT04927221 · COMPLETED

Trial details

NCT number: NCT04927221
Sponsor: Guangzhou JOYO Pharma Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypercholesterolemia

Start date: 2021-04-01
Primary completion: 2021-12-21
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.